.Merck trumps profits desires, rears purchases expectation on solid requirement for best drugs like Keytruda CNBCMerck & Co. (MRK US) Beats Income Estimates as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Titan Posts Strong End Results, Yet Overview Falls Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats income and purchases desires among Keytruda strong point, but supplies mixed full-year outlook MarketWatch.